These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16922340)

  • 21. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Menopause].
    d'Arailh AS; Lopes P
    Rev Prat; 2006 Oct; 56(16):1841-6. PubMed ID: 17315513
    [No Abstract]   [Full Text] [Related]  

  • 25. Osteoporosis detection: is BMD testing the future?
    Olson AF
    Nurse Pract; 2007 Jun; 32(6):20-7; quiz 28. PubMed ID: 17557021
    [No Abstract]   [Full Text] [Related]  

  • 26. Breaking the mold: treating osteoporosis.
    Cornell DH
    N J Med; 1997 Dec; 94(12):39-41. PubMed ID: 9420441
    [No Abstract]   [Full Text] [Related]  

  • 27. [Estrogens, anabolic steroids and postmenopausal osteoporosis: what are the facts?].
    Birkenhäger JC
    Ned Tijdschr Geneeskd; 1991 Jun; 135(22):973-5. PubMed ID: 2062392
    [No Abstract]   [Full Text] [Related]  

  • 28. Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.
    Sacco SM; Jiang JM; Reza-López S; Ma DW; Thompson LU; Ward WE
    Menopause; 2009; 16(3):545-54. PubMed ID: 19182694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.
    Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Marques-Neto JF; Weryha G; Verbruggen N; Hustad CM; Mahlis EM; Melton ME
    Int J Clin Pract; 2008 Apr; 62(4):575-84. PubMed ID: 18324951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Men also need bone protection].
    MMW Fortschr Med; 2006 Nov; 148(46):48-9. PubMed ID: 17615790
    [No Abstract]   [Full Text] [Related]  

  • 31. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone density vs bone quality: what's a clinician to do?
    Licata A
    Cleve Clin J Med; 2009 Jun; 76(6):331-6. PubMed ID: 19487553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is treatment of early postmenopausal women with bisphosphonates justified?
    Epstein S
    Int J Clin Pract; 2007 Jun; 61(6):963-71. PubMed ID: 17504359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoporosis prevention and management: an evidence-based review.
    Kleerekoper M; Gold DT
    Clin Obstet Gynecol; 2008 Sep; 51(3):556-63. PubMed ID: 18677150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical value of bone densitometry.
    Sartoris DJ
    AJR Am J Roentgenol; 1994 Jul; 163(1):133-5. PubMed ID: 8010199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of osteoporosis in an active female patient?].
    Fassbender WJ
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2416. PubMed ID: 18988136
    [No Abstract]   [Full Text] [Related]  

  • 39. Nutrient intake risk factors of osteoporosis in postmenopausal women.
    Kim J; Lim SY; Kim JH
    Asia Pac J Clin Nutr; 2008; 17(2):270-5. PubMed ID: 18586647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soft tissue body composition during prevention and treatment of postmenopausal osteoporosis assessed by photon absorptiometry.
    Hassager C
    Dan Med Bull; 1991 Oct; 38(5):380-9. PubMed ID: 1802623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.